These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38739094)

  • 21. Selective response to rituximab in a young child with MuSK-associated myasthenia gravis.
    Govindarajan R; Iyadurai SJ; Connolly A; Zaidman C
    Neuromuscul Disord; 2015 Aug; 25(8):651-2. PubMed ID: 25998611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effect of tocilizumab in myasthenia gravis refractory to rituximab.
    Jonsson DI; Pirskanen R; Piehl F
    Neuromuscul Disord; 2017 Jun; 27(6):565-568. PubMed ID: 28433474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Maddison P; McConville J; Farrugia ME; Davies N; Rose M; Norwood F; Jungbluth H; Robb S; Hilton-Jones D
    J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):671-3. PubMed ID: 20392977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Lasting Rituximab-Induced Reduction of Specific-But Not Total-IgG4 in MuSK-Positive Myasthenia Gravis.
    Marino M; Basile U; Spagni G; Napodano C; Iorio R; Gulli F; Todi L; Provenzano C; Bartoccioni E; Evoli A
    Front Immunol; 2020; 11():613. PubMed ID: 32431692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab in refractory myasthenia gravis: Extended prospective study results.
    Beecher G; Anderson D; Siddiqi ZA
    Muscle Nerve; 2018 Sep; 58(3):452-455. PubMed ID: 29742795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of rituximab in muscle-specific tyrosine kinase antibody-positive myasthenia gravis: Preliminary observations from a tertiary care center in Northern India.
    Sachdeva J; Mahesh KV; Shree R; Jain G; Kapila AT; Shashikala TP; Goyal MK; Modi M; Lal V
    Indian J Pharmacol; 2020; 52(1):49-52. PubMed ID: 32201447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nomogram for the acute exacerbation of acetylcholine receptor antibody-positive generalized myasthenia gravis.
    Chen J; Li S; Feng L; Wang H; Huang X; Feng H
    Neurol Sci; 2023 Mar; 44(3):1049-1057. PubMed ID: 36369308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].
    Jiang W; Feng MY; Dong XY; Dong SM; Zheng JX; Liu XM; Liu WJ; Yan J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):748-754. PubMed ID: 31422613
    [No Abstract]   [Full Text] [Related]  

  • 29. Rituximab in late-onset myasthenia gravis is safe and effective.
    Sahai SK; Maghzi AH; Lewis RA
    Muscle Nerve; 2020 Sep; 62(3):377-380. PubMed ID: 32239711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis.
    Iorio R; Damato V; Alboini PE; Evoli A
    J Neurol; 2015 May; 262(5):1115-9. PubMed ID: 25308632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nomogram predicting severe COVID-19 based on a large study cohort from China.
    Liu S; Luo H; Lei Z; Xu H; Hao T; Chen C; Wang Y; Xie J; Liu L; Ju S; Qiu H; Wang D; Yang Y
    Am J Emerg Med; 2021 Dec; 50():218-223. PubMed ID: 34392141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Rituximab in Refractory Generalized anti-AChR Myasthenia Gravis.
    Landon-Cardinal O; Friedman D; Guiguet M; Laforêt P; Heming N; Salort-Campana E; Jouen F; Allenbach Y; Boyer O; Chatenoud L; Eymard B; Sharshar T; Benveniste O
    J Neuromuscul Dis; 2018; 5(2):241-249. PubMed ID: 29865089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Remission With Low-Dose Rituximab in Myasthenia Gravis: A Retrospective Study.
    Castiglione JI; Rivero AD; Barroso F; Brand P; Lautre A; Kohler AA
    J Clin Neuromuscul Dis; 2022 Sep; 24(1):18-25. PubMed ID: 36005470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longstanding and Refractory Anti-Muscle Specific Tyrosine Kinase Antibody-Associated Myasthenia Gravis (Anti-MuSK-MG) in a Child Successfully Treated with Rituximab.
    Weger S; Appendino JP; Clark IH
    J Binocul Vis Ocul Motil; 2019; 69(1):26-29. PubMed ID: 30811277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical Trial.
    Piehl F; Eriksson-Dufva A; Budzianowska A; Feresiadou A; Hansson W; Hietala MA; Håkansson I; Johansson R; Jons D; Kmezic I; Lindberg C; Lindh J; Lundin F; Nygren I; Punga AR; Press R; Samuelsson K; Sundström P; Wickberg O; Brauner S; Frisell T
    JAMA Neurol; 2022 Nov; 79(11):1105-1112. PubMed ID: 36121672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
    Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
    [No Abstract]   [Full Text] [Related]  

  • 37. Construction and validation of a nomogram for predicting prolonged air leak after minimally invasive pulmonary resection.
    Li R; Xue M; Ma Z; Qu C; Wang K; Zhang Y; Yue W; Zhang H; Tian H
    World J Surg Oncol; 2022 Aug; 20(1):249. PubMed ID: 35922824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Validation of a Nomogram for Predicting Generalization in Patients With Ocular Myasthenia Gravis.
    Ruan Z; Sun C; Lang Y; Gao F; Guo R; Xu Q; Yu L; Wu S; Lei T; Liu Y; Zhang M; Li H; Tang Y; Gao T; Gao Y; Lu X; Li Z; Chang T
    Front Immunol; 2022; 13():895007. PubMed ID: 35874731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Efficacy and Safety of Low-Dose Rituximab in Patients with Refractory Myasthenia Gravis.
    Ren J; Wang J; Liu R; Jin Y; Guo J; Yao Y; Luo J; Hao H; Gao F
    Eur Neurol; 2023; 86(6):387-394. PubMed ID: 37778340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting symptomatic post-hepatectomy liver failure in patients with hepatocellular carcinoma: development and validation of a preoperative nomogram.
    Long H; Peng C; Ding H; Zheng Y; Zhou J; Chen W; Zhong X; Shi Y; Duan Y; Xie X; Kuang M; Xie X; Lin M
    Eur Radiol; 2023 Nov; 33(11):7665-7674. PubMed ID: 37314474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.